DalsnaFinance

USA Cell Therapy Manufacturing Market Highlights Lonza Group as Global Market Reaches USD 23.2 Billion by 2036 at 14.1% CAGR | Future Market Insights

Markets PR Newswire By PR Newswire 27 Jul 2026 16:00 1 min read
USA Cell Therapy Manufacturing Market Highlights Lonza Group as Global Market Reaches USD 23.2 Billion by 2036 at 14.1% CAGR | Future Market Insights

NEWARK, Del., July 27, 2026 /PRNewswire/ -- The Cell Therapy Manufacturing Market is projected to witness rapid expansion as the global biopharmaceutical industry accelerates commercialization of advanced cell therapies and regenerative medicines. According to Future Market Insights...

NEWARK, Del., July 27, 2026 /PRNewswire/ -- The Cell Therapy Manufacturing Market is projected to witness rapid expansion as the global biopharmaceutical industry accelerates commercialization of advanced cell therapies and regenerative medicines. According to Future Market Insights...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.